Career Opportunities at MRC-Holland
MRC-Holland is a fast-growing biotechnology company based in the Amsterdam Baarsjes. MRC-Holland consists of a multinational team of more than 80 employees. MRC-Holland is the inventor of the Multiplex Ligation-dependent Probe Amplification (MLPA) technique, a sensitive method to detect copy number changes in genes. MLPA is used in hundreds of labs and hospitals worldwide for many different applications, including mutation detection in hereditary diseases and subtyping of tumours. Because of continuous growth, we are looking for:



Which personal data do we collect of our applicants? Please see our privacy policy.
Improved Products
P389-MLL2
Kabuki syndrome
P324-22q11
22q11
P202-IKZF1-ERG
Acute lymphoblastic leukemia (ALL); Chronic myeloid leukemia (CML); Common variable immunodeficiency (CVID)
ME001-Tumour suppressor mix 1
Tumour suppressor genes
ME034-Multi-locus Imprinting
Multi-locus imprinting defects; To distinguish maternal and paternal triploidies
Newsletter  |  Home  |  Privacy Policy  |  Terms and Conditions  |  Search  |  Sitemap  |  Copyright © 2019 MRC-Holland